about
Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approachCellular replacement therapy for Parkinson's disease--where we are today?Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.Longitudinal monitoring of stem cell grafts in vivo using magnetic resonance imaging with inducible maga as a genetic reporter.Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.Stem cell therapy for Parkinson's disease.Changes in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons.Stem cell-based therapy for Parkinson's disease.Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Function of Wnts in dopaminergic neuron development.The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's diseaseGlial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.Surgical management of Parkinson's disease: update and review.Recent preclinical evidence advancing cell therapy for Alzheimer's disease.BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells.Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells.Detection of calcium transients in embryonic stem cells and their differentiated progenyNeural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors.Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.Regenerating movements: embryonic stem cells and the politics of potentiality.
P2860
Q28078109-6EC8549D-D4B0-4622-AB49-C50E18760B3BQ28206557-0C96E02F-6B7C-492E-B5F6-2EA997FFD7B4Q33565361-14E10632-4DDD-4EBB-AB04-34F32573638FQ34086475-66AF9767-D90D-40BA-9361-4D82A56A2502Q34371507-ED7B7D90-167F-4D08-A70E-8BF67A8BB123Q35236822-D12ABB01-A9FE-4559-98E1-EFAFA5D740C0Q36094337-820D76F9-D8E2-4C0E-82B5-B5914F080090Q36309562-E67ED3BD-3BF1-4FE6-B006-E706D99AD512Q36458442-08380998-1BCB-4829-A041-20E264F35D2EQ36565698-0EBEF9F0-60A0-4755-8184-2FE7C69792D2Q36709957-CC9D3E25-32D9-4561-8F7E-0DBA5B1CA61FQ37236894-C7BBED53-59EE-4A7E-AED8-7C53ECA18ED2Q37333346-581C5577-3C57-419F-80F8-88B2C5022C42Q37766664-6A92A8DD-DAF9-4E22-8F73-29C88758475CQ38024220-90F40635-F009-4152-8A58-65152DB638B2Q38710630-83FCC692-829C-4FAD-BB9E-F9737AEC68A4Q39767290-19581137-10BD-4A44-ABC3-0CA55A8F467EQ39846234-721DBB2C-14CC-49BA-8768-782ECFA42147Q40084730-2FBEA05F-3101-4C45-AA89-2E3BB516410DQ44658178-02F2A8C4-D985-4D3F-8194-C9C07B403451Q45941984-14F39B3F-A5FB-43E4-83C1-32A23F59936EQ46317180-EBFA98BC-49BD-4A56-8ED5-DBC63C818890
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stem cells in the treatment of Parkinson's disease.
@ast
Stem cells in the treatment of Parkinson's disease.
@en
Stem cells in the treatment of Parkinson's disease.
@nl
type
label
Stem cells in the treatment of Parkinson's disease.
@ast
Stem cells in the treatment of Parkinson's disease.
@en
Stem cells in the treatment of Parkinson's disease.
@nl
prefLabel
Stem cells in the treatment of Parkinson's disease.
@ast
Stem cells in the treatment of Parkinson's disease.
@en
Stem cells in the treatment of Parkinson's disease.
@nl
P1476
Stem cells in the treatment of Parkinson's disease
@en
P2093
P304
P356
10.1016/S0361-9230(01)00772-9
P577
2002-04-01T00:00:00Z